Figure 3.
Pharmacokinetic profile of RG7204/PLX4032 in humans. Dose‐dependent exposure (panel A) and relatively constant daily exposure at steady state (panel B) (Flaherty et al., 2010).
Pharmacokinetic profile of RG7204/PLX4032 in humans. Dose‐dependent exposure (panel A) and relatively constant daily exposure at steady state (panel B) (Flaherty et al., 2010).